Soluble galectin-3 is associated with premature myocardial infarction.

about

Prognostic biomarkers in acute coronary syndrome

P2860

Q26738521-CC543419-C17C-49A0-905A-19E18C6A0EC6

P2860

Soluble galectin-3 is associated with premature myocardial infarction.

Item

http://www.wikidata.org/entity/Q40908249

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Soluble galectin-3 is associated with premature myocardial infarction.

@en

type

Item

label

Soluble galectin-3 is associated with premature myocardial infarction.

@en

prefLabel

Soluble galectin-3 is associated with premature myocardial infarction.

@en

P1476

Soluble galectin-3 is associated with premature myocardial infarction

@en

P2093

Arman Alimohammadi

http://www.w3.org/2001/XMLSchema#string

Franz Wiesbauer

http://www.w3.org/2001/XMLSchema#string

Hermann Blessberger

http://www.w3.org/2001/XMLSchema#string

Irene M Lang

http://www.w3.org/2001/XMLSchema#string

Kurt Huber

http://www.w3.org/2001/XMLSchema#string

Martin Schillinger

http://www.w3.org/2001/XMLSchema#string

Noemi Pavo

http://www.w3.org/2001/XMLSchema#string

P2860

Human galectin-3 is a novel chemoattractant for monocytes and macrophages

Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation; recommendations of the Task Force of the European Society of Cardiology.

Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction.

Premature myocardial infarction is strongly associated with increased levels of remnant cholesterol.

Galectin-3 gene inactivation reduces atherosclerotic lesions and adventitial inflammation in ApoE-deficient mice.

Inflammation and plaque vulnerability.

Atherosclerosis: current pathogenesis and therapeutic options.

Biomarkers of plaque instability.

Galectin-3 and post-myocardial infarction cardiac remodeling.

Clinical profile and impact of family history of premature coronary artery disease on clinical outcomes of patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: analysis from the HORIZONS-AMI Trial.

P304

386-391

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/ECI.12605

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-03-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26880404

http://www.w3.org/2001/XMLSchema#string

Soluble galectin-3 is associated with premature myocardial infarction.

about

P2860

P2860

Soluble galectin-3 is associated with premature myocardial infarction.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698